Fig. 1
From: Operative invasiveness does not affect the prognosis of patients with non-small cell lung cancer
a Relapse-free survival rate in the VATS group was significantly longer than in the thoracotomy group. b Relapse-free survival in patients with a wound length of ≤10 cm was significantly longer than that in patients with a wound length of > 10 cm. c Relapse-free survival in patients with an operation time of ≤248 min was significantly longer than that in patients with an operation time of > 248 min. d Relapse-free survival in patients with a preCRP level of ≤0.14 was significantly longer than that in patients with a preCRP level of > 0.14. e Relapse-free survival in patients with a postCRP level of ≤14.49 was significantly longer than that in patients with a postCRP level of > 14.49